The genetic testing industry is becoming the commanding height of competition among countries in the world. The development momentum of the genetic testing industry in developed countries is good, while the development of the genetic testing industry in China is slow and the market of genetic testing is still somewhat cold. The genetic testing industry in China is in urgent need of development.

Shanpu consulting pharmaceutical industry analysts point out that: operation is not standard, the lack of industry standards and other serious constraints on the development of China's genetic testing market.

For the clinical application and industrial development of gene testing in China, we should learn from the foreign management model, strengthen the research on technical methods, and give more policy support at the national level.

At present in the United States, gene sequencing industry is becoming a sunrise industry is widely optimistic.

Data show that the market is worth several billion dollars a year, and the market for genetic testing is growing every year.

As the technology matures, the price of genetic testing is falling.

Testing the entire genome sequence in the United States costs only a few thousand dollars, and some individual genetic testing services in China cost only a few hundred yuan.

China should learn from the development model of the United States, which currently has nearly a quarter of a million clia LABS managed by another government agency, CMS.

In this way, the quality assurance of clinical laboratory can be realized, which can not only control the risk, but also accelerate the clinical application of new technology.

In policy, also ought to undertake corresponding support.

At present, China's gene sequencing companies are mainly small and medium-sized enterprises, some companies with advanced technology are mainly scientific research, few sequencing projects for the public, and they lack experience in market operation, resulting in the slow development of China's gene testing industry.

Genetic testing instruments are mostly overseas companies spend huge research and development, our country has been buying foreign instruments, reagents for research and clinical development, countries should in aspects and so on research and development, production and pricing to give strong support, especially in the area of gene sequencing technology is utilized to avoid the birth defects, more research is needed, so as to guide the domestic independent innovation.

China's gene sequencing industry is in urgent need of development and growth, according to the 2014-2017 analysis report on investment prospects of China's gm industry released by shangpu consulting.

Some foreign gene-testing companies have begun to keep an eye on the Chinese market and enter strongly, impacting the already weak gene industry.

China should draw lessons from foreign development models, introduce relevant support policies, and conduct standard operations so as to develop the gene sequencing industry in an orderly manner.